Works matching IS 00070920 AND DT 2024 AND VI 131 AND IP 5
Results: 18
Editorial Expression of Concern: Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Potential role of the CD39-CD73 ATP-adenosine pathway in platelet mediated dissemination of circulating tumour cells.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Correction to: Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Establishment of a trastuzumab-resistant extramammary Paget disease model: loss of PTEN as a potential mechanism.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 944, doi. 10.1038/s41416-024-02788-3
- By:
- Publication type:
- Article
Invasive recurrence after breast conserving treatment of ductal carcinoma in situ of the breast in the Netherlands: time trends and the association with tumour grade.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 852, doi. 10.1038/s41416-024-02785-6
- By:
- Publication type:
- Article
PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 820, doi. 10.1038/s41416-024-02776-7
- By:
- Publication type:
- Article
DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 895, doi. 10.1038/s41416-024-02780-x
- By:
- Publication type:
- Article
Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology – an analysis of the closed cohorts of a multicentre prospective study.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 843, doi. 10.1038/s41416-024-02789-2
- By:
- Publication type:
- Article
Efficacy of a nurse-led sexual rehabilitation intervention for women with gynaecological cancers receiving radiotherapy: results of a randomised trial.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 808, doi. 10.1038/s41416-024-02775-8
- By:
- Publication type:
- Article
Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 832, doi. 10.1038/s41416-024-02784-7
- By:
- Publication type:
- Article
Cancer cell extravasation requires <sup>i</sup>plectin-mediated delivery of MT1-MMP at invadopodia.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 931, doi. 10.1038/s41416-024-02782-9
- By:
- Publication type:
- Article
ESCCPred: a machine learning model for diagnostic prediction of early esophageal squamous cell carcinoma using autoantibody profiles.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 883, doi. 10.1038/s41416-024-02781-w
- By:
- Publication type:
- Article
HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 918, doi. 10.1038/s41416-024-02774-9
- By:
- Publication type:
- Article
An 18-gene signature of recurrence-associated endothelial cells predicts tumor progression and castration resistance in prostate cancer.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 870, doi. 10.1038/s41416-024-02761-0
- By:
- Publication type:
- Article
Presence of Fusobacterium nucleatum in relation to patient survival and an acidic environment in oesophagogastric junction and gastric cancers.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 797, doi. 10.1038/s41416-024-02753-0
- By:
- Publication type:
- Article
ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 905, doi. 10.1038/s41416-024-02745-0
- By:
- Publication type:
- Article
Introduction and impact of routine whole genome sequencing in the diagnosis and management of sarcoma.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 860, doi. 10.1038/s41416-024-02721-8
- By:
- Publication type:
- Article
Why does circadian timing of administration matter for immune checkpoint inhibitors' efficacy?
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 5, p. 783, doi. 10.1038/s41416-024-02704-9
- By:
- Publication type:
- Article